Isomorphic Labs Chief Executive Officer Demis Hassabis stated that the $5 billion in new capital will accelerate the company's platform scale toward designing hundreds of drugs annually and moving into clinical trials
Agree
Disagree
Overview
Debates
Related claims
Topics
Sources
Best
Space 41e851
Loading debates…
Opening sign-in…